Advertisement

Topics

Closing Claris deal, Baxter set to invest in three new plants

10:22 EDT 3 Aug 2017 | BioPharmaDive

Baxter expects the injectable drugmaker will bring it $55 million worth of incremental sales during 2017.

Original Article: Closing Claris deal, Baxter set to invest in three new plants

NEXT ARTICLE

More From BioPortfolio on "Closing Claris deal, Baxter set to invest in three new plants"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...